Copenhagen-based Bactolife, a startup that specializes in gut microbiome health, announced on Tuesday that it has secured $5M (approximately €5M) from The Bill & Melinda Gates Foundation.
The company says it will use the capital to accelerate the development of Binding Proteins, a novel biologic solution to reduce the risk of gut infections in humans and animals.
Founded Bactolife in 2017 with the mission to develop binding proteins to help maintain healthy microbiomes in humans and animals.
Bactolife uses its proprietary Binding Protein technology to develop novel biological solutions to strengthen the gut microbiome and help solve the challenge of antimicrobial resistance development and the general burden of infectious diseases.
The company says its proprietary platform comprises technology for selecting and producing Binding Proteins without directly targeting growth or killing bacteria.
Read more on Tech Gist Africa:
